| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |